-
CSR Summary Not Yet Available
-
NCT03775421
-
Primary Citation
-
Data Specification Not Yet Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameMacitentanProduct NameOPSUMIT®Therapeutic AreaEnrollment112% Female30.6%% White78.4%
Product ClassEndothelin Receptor AntagonistSponsor Protocol NumberAC-055H302Data PartnerJohnson & JohnsonCondition StudiedCongenital Heart DiseaseMean/Median Age (Years)25.1
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available